KX-826, a new drug in development for the treatment of androgenic alopecia undergoing clinical trials in both China and the United States, treats hair loss by antagonizing the action of androgen receptors in a different mode of action than any of the existing FDA-approved drugs for AGA alopecia. Let’s look forward to this new treatment for hair loss. What is …